| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Stroke. 2005;36:189.)
© 2005 American Heart Association, Inc.
Advances in Stroke 2004 |
From the Neuroprotection Research Laboratory (E.H.L.), Departments of Radiology and Neurology, Massachusetts General Hospital, and Program in Neuroscience, Harvard Medical School, Charlestown, Mass; the Neurovascular Regulation and Stroke Laboratory (M.A.M.), Departments of Radiology and Neurology, Massachusetts General Hospital, Harvard Medical School, Charlestown, Mass; and the Neural Environment Cluster (T.P.J.), National Institute of Neurological Disorders and Stroke, National Institutes of Health, Bethesda, Md.
Correspondence to Dr Eng H. Lo, Neuroprotection Research Laboratory, Harvard Medical School, MGH East 149-2401, Charlestown, MA 02129. E-mail Lo@helix.mgh.harvard.edu
Key Words: Advances in Stroke apoptosis erythopoietin ischemia neuroprotective agents
An extract of the first 250 words of the full text is provided, because this article has no abstract. |
| Introduction |
|---|
Although the precise timing and cellular pathways involved are not fully understood, it is believed that mechanisms actively promoting cell death are triggered after stroke. Remarkable progress has been made in dissecting these mechanisms over the past 3 decades. Three major pathways have emerged: excitotoxicity, oxidative stress, and apoptosis, and they are inextricably linked. Here, we explore the notion that stroke is most fruitfully investigated by an integrative "systems biology" approach that encompasses cell death and survival signaling within all components of the neurovascular unit.
| Cell Death: A Convergence of Factors |
|---|
This article has been cited by other articles:
![]() |
M. O. Breckwoldt, J. W. Chen, L. Stangenberg, E. Aikawa, E. Rodriguez, S. Qiu, M. A. Moskowitz, and R. Weissleder Tracking the inflammatory response in stroke in vivo by sensing the enzyme myeloperoxidase PNAS, November 25, 2008; 105(47): 18584 - 18589. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Bull, J. P. Finkelstein, J. Galvez, G. Sanchez, P. Donoso, M. I. Behrens, and C. Hidalgo Ischemia Enhances Activation by Ca2+ and Redox Modification of Ryanodine Receptor Channels from Rat Brain Cortex J. Neurosci., September 17, 2008; 28(38): 9463 - 9472. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Jin, K. Arai, Y. Murata, S. Wang, M. F. Stins, E. H. Lo, and K. van Leyen Protecting Against Cerebrovascular Injury: Contributions of 12/15-Lipoxygenase to Edema Formation After Transient Focal Ischemia Stroke, September 1, 2008; 39(9): 2538 - 2543. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. L. Sacchetti Is It Time to Definitely Abandon Neuroprotection in Acute Ischemic Stroke? Stroke, June 1, 2008; 39(6): 1659 - 1660. [Full Text] [PDF] |
||||
![]() |
S. Guo, W. J. Kim, J. Lok, S.-R. Lee, E. Besancon, B.-H. Luo, M. F. Stins, X. Wang, S. Dedhar, and E. H. Lo Neuroprotection via matrix-trophic coupling between cerebral endothelial cells and neurons PNAS, May 27, 2008; 105(21): 7582 - 7587. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Sun, H. H. Marti, and R. Veltkamp Hyperbaric Oxygen Reduces Tissue Hypoxia and Hypoxia-Inducible Factor-1{alpha} Expression in Focal Cerebral Ischemia Stroke, March 1, 2008; 39(3): 1000 - 1006. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. N. Nagaraja, K. Karki, J. R. Ewing, R. L. Croxen, and R. A. Knight Identification of Variations in Blood-Brain Barrier Opening After Cerebral Ischemia by Dual Contrast-Enhanced Magnetic Resonance Imaging and T1sat Measurements Stroke, February 1, 2008; 39(2): 427 - 432. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Chu, S.-T. Lee, D.-I. Sinn, S.-Y. Ko, E.-H. Kim, J.-M. Kim, S.-J. Kim, D.-K. Park, K.-H. Jung, E.-C. Song, et al. Pharmacological Induction of Ischemic Tolerance by Glutamate Transporter-1 (EAAT2) Upregulation Stroke, January 1, 2007; 38(1): 177 - 182. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. van Leyen, H. Y. Kim, S.-R. Lee, G. Jin, K. Arai, and E. H. Lo Baicalein and 12/15-Lipoxygenase in the Ischemic Brain Stroke, December 1, 2006; 37(12): 3014 - 3018. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Wu, S. Christensen, N. Hjort, R. M. Dijkhuizen, T. Kucinski, J. Fiehler, G. Thomalla, J. Rother, and L. Ostergaard Characterizing physiological heterogeneity of infarction risk in acute human ischaemic stroke using MRI Brain, September 1, 2006; 129(9): 2384 - 2393. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. B. Tatro Melanocortins Defend their Territory: Multifaceted Neuroprotection in Cerebral Ischemia. Endocrinology, March 1, 2006; 147(3): 1122 - 1125. [Full Text] [PDF] |
||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2005 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |